Navigation Links
www.Joyn7030.com, A New Web Site Dedicated to Helping Women Fight Joint Pain, Launches
Date:10/17/2008

Site Offers Advice for Joint-Pain Sufferers Who are Confused and Concerned About Their Options for Fighting Joint Pain; Examines New Research That

Reveals Truth About Makeup of Joint Cartilage and Offers Hope

EGG HARBOR TOWNSHIP, N.J., Oct. 17 /PRNewswire/ -- A new Web site dedicated to helping women fight joint pain, http://www.Joyn7030.com, launched today. The site is designed to help joint-pain sufferers take control of their lives with a unique 70/30 joint-health plan. The site also examines new research that reveals the truth about the makeup of joint cartilage, provides expert opinions on why glucosamine has not met expectations in supporting joint health, and offers a place for women to connect and share ideas on living pain-free.

"Our goal is to help the many people suffering from joint pain live active, healthy, pain-free lives," said Leonard P. Smith, CEO, BSP Pharma, creator of the site. "Following the recent announcement from the National Center for Complementary and Alternative Medicine at the National Institutes of Health regarding the ineffectiveness of glucosamine and chondroitin in treating chronic joint conditions, many joint-pain sufferers are confused and concerned about their options. This site can help clear the confusion."

Because women have less joint cartilage than men, when it breaks down, it affects them in more places with more intensity. In fact, after menopause women experience a significant decline in joint collagen, which makes up 70 percent of cartilage and provides structure, strength and smoothness to the joint.

http://www.Joyn7030.com examines exciting new research that actually explains why glucosamine and chondroitin could not meet expectations as a comprehensive joint treatment because they are only 30 percent of the solution, and don't address the deterioration of Type II collagen, which makes up 70 percent of joint cartilage.

The breakthrough research by Dr. Phillip Cheras, pioneering researcher, published author, and former deputy director of the Australian Center for Complementary Medicine Education and Research, found that adults who regularly took a patent-pending shea treiterpene concentrate had remarkable results. Cheras observed that study participants experienced dramatic reduction in joint pain and joint-specific inflammation, while stabilizing the breakdown of Type II collagen. When joint collagen is stabilized, it may complement the effects of glucosamine for 100 percent joint support.

Other features of the site include:

-- Joyn the Movement Support Network, where women can get answers from an expert and develop their own support network, because everything is easier when you know you are not alone.

-- The 70/30 Complete Joint Health Plan(TM), which gives women tools, from exercise tips to recipes, and guidance so they can get more relief, freedom, and health-and live life 100 percent. Each step works synergistically with the others, so women have the greatest chance for their 100 percent when they make the plan part of their everyday routine. A few small changes can go a long way, especially if they're tailored to the way women live.

Contact:

Jeff Vaughan

VONCOM

610-533-4264

jv@voncom.com


'/>"/>
SOURCE http://www.Joyn7030.com
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Scripps Research Institute and IAVI launch worlds first dedicated HIV neutralizing antibody center
2. First Dedicated Cancer Hospital Coming to North Texas
3. Cleveland Clinic Launches Fully Dedicated International Comprehensive Critical Care Program
4. Medicexchange.com Launches a New Dedicated Nuclear Medicine and Molecular Imaging Community for Medical Imaging Professionals
5. Nonprofit Organization Dedicated to Helping Young Adult Cancer Survivors Raises $4500 for Leanna Elizalde
6. SCAN Health Plan Announces Creation of $205 Million Foundation Dedicated to the Needs of Seniors
7. Thomson Scientific To Honor Australias Top Researchers With Dedicated Australian Research Day
8. American Heart Association Themed Issue Journal Report: Journal Edition Dedicated to Womens Unique Hypertension Issues
9. StopMusclePain.com Launched as Only Website Dedicated to Reversing Back Pain
10. Video Feed: Jenny McCarthy Honored at LEGOLAND(R) Californias Tree Lighting Ceremony Dedicated to Autism Awareness
11. Special Olympics Special Spirit in China Award Of Excellence Presented to Dedicated Friends of Special Olympics and City of Shanghai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Nashville, Tennessee (PRWEB) , ... ... ... leader in strategic interoperability, today announced that the company will provide alerting ... platform. CIHIE has been recently awarded $1.7 million in federal funds as ...
(Date:12/5/2016)... Shrewsbury, PA (PRWEB) , ... December 05, 2016 , ... ... of necessity for the betterment of both the smaller rider and the horse. Smaller ... performance. The Saddle Sidekick is designed to fit over a properly fitted western saddle ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... of physical therapist assistants, under direct supervision of a licensed physical therapist, to ... therapy receives a consultation and treatment plan from a licensed physical therapist (PT) ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Facial Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic ... Aesthetic & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading ...
(Date:12/4/2016)... California (PRWEB) , ... December 03, 2016 , ... ... lower thirds, 4 transitions and many more tools allowing FCPX editors to create ... of Pixel Film Studios. , Perfect Harmony contains a beautifully designed 3D ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... OSWEGO, Ore. , Dec. 5, 2016   ... the BioInsight clinical study. The study evaluates the safety ... insertion procedure in an office setting. BioMonitor ... ® technology that is placed underneath a patient,s ... fibrillation and syncope (fainting). Atrial fibrillation is a leading ...
(Date:12/5/2016)... PITTSBURGH , Dec. 5, 2016  Wellbridge Health and ... innovative digital health solutions to Medicare and Medicaid plan members ... effort targeted at the unique needs of this group of ... on social work philosophies to provide insight into members, daily ... , ...
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
Breaking Medicine Technology: